- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Patent holdings for IPC class C12Q 1/6886
Total number of patents in this class: 12370
10-year publication summary
|
297
|
410
|
813
|
1152
|
1236
|
1185
|
1271
|
1349
|
1303
|
1097
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1158 |
299 |
| The Regents of the University of California | 20303 |
189 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
177 |
| The Johns Hopkins University | 5756 |
170 |
| Guardant Health, Inc. | 471 |
161 |
| Mayo Foundation for Medical Education and Research | 3295 |
144 |
| The General Hospital Corporation | 4801 |
143 |
| Foundation Medicine, Inc. | 376 |
140 |
| The Board of Trustees of the Leland Stanford Junior University | 6541 |
123 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3374 |
116 |
| Memorial Sloan-Kettering Cancer Center | 1992 |
114 |
| Board of Regents, The University of Texas System | 5946 |
106 |
| Exact Sciences Corporation | 307 |
97 |
| The Broad Institute, Inc. | 1875 |
94 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3003 |
94 |
| Genentech, Inc. | 4016 |
88 |
| Grail, Inc. | 235 |
87 |
| National Cancer Center | 430 |
87 |
| Centre National de La Recherche Scientifique | 10706 |
77 |
| Toray Industries, Inc. | 7015 |
71 |
| Other owners | 9793 |